BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/27/2024 11:58:45 AM | Browse: 134 | Download: 469
 |
Received |
|
2023-12-20 15:39 |
 |
Peer-Review Started |
|
2023-12-20 15:39 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-01-05 23:40 |
 |
Revised |
|
2024-01-10 15:56 |
 |
Second Decision |
|
2024-01-18 02:54 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-01-18 06:26 |
 |
Articles in Press |
|
2024-01-18 06:26 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-02-06 07:15 |
 |
Publish the Manuscript Online |
|
2024-02-27 11:58 |
ISSN |
1948-5182 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Review |
Article Title |
Precision targeting in hepatocellular carcinoma: Exploring ligand-receptor mediated nanotherapy
|
Manuscript Source |
Invited Manuscript |
All Author List |
Xia-Qing Zhou, Ya-Ping Li and Shuang-Suo Dang |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Xi'an Jiaotong University Medical "Basic-Clinical" Integration Innovation Project |
YXJLRH2022067 |
Shaanxi Postdoctoral Research Program “Orlistat-loaded Nanoparticles as A Targeted Therapeutical Strategy for The Enhanced Treatment of Liver Cancer” |
2023BSHYDZZ09 |
|
Corresponding Author |
Shuang-Suo Dang, PhD, Professor, Department of Infectious Diseases, Second Affiliated Hospital of Xi'an Jiaotong University, No. 157 Xiwu Road, Xincheng District, Xi'an 710004, Shaanxi Province, China. dangshuangsuo123@xjtu.edu.cn |
Key Words |
Targeting; Hepatocellular carcinoma; Receptor; Nanomedicine; Chemotherapy |
Core Tip |
This review explores the innovative field of nanoparticle-mediated targeted drug delivery in hepatocellular carcinoma (HCC), focusing on the critical role of various overexpressed cellular receptors in improving the therapeutic specificity and efficacy of nanomedicines. It comprehensively analyzes recent advances in the development of receptor-targeted nanoparticles, revealing the complex mechanisms behind receptor-mediated drug delivery at the nanoscale. This exploration not only emphasizes the potential of nano-therapies to transform the treatment of HCC, but also provides valuable insights for future research and clinical applications. |
Publish Date |
2024-02-27 11:58 |
Citation |
Zhou XQ, Li YP, Dang SS. Precision targeting in hepatocellular carcinoma: Exploring ligand-receptor mediated nanotherapy. World J Hepatol 2024; 16(2): 164-176 |
URL |
https://www.wjgnet.com/1948-5182/full/v16/i2/164.htm |
DOI |
https://dx.doi.org/10.4254/wjh.v16.i2.164 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345